Association of immune response to endothelial cell growth factor with early disseminated and late manifestations of lyme disease but not posttreatment lyme disease syndrome

Kevin S. Tang; Mark S. Klempner; Gary P. Wormser; Adriana R. Marques; Armin Alaedini

Journal ArticleOPEN ACCESS

Association of immune response to endothelial cell growth factor with early disseminated and late manifestations of lyme disease but not posttreatment lyme disease syndrome

Clinical Infectious Diseases (2015) 61(11) 1703-1706

DOI: 10.1093/cid/civ638

7Citations

19Readers

Abstract

Endothelial cell growth factor has been recently proposed as a potential autoantigen in manifestations of Lyme disease that are thought to involve immune-mediated mechanisms. Our findings indicate that a humoral immune response to this protein is not associated with posttreatment Lyme disease syndrome.

Author supplied keywords

Cite

CITATION STYLE

APA

Tang, K. S., Klempner, M. S., Wormser, G. P., Marques, A. R., & Alaedini, A. (2015). Association of immune response to endothelial cell growth factor with early disseminated and late manifestations of lyme disease but not posttreatment lyme disease syndrome. Clinical Infectious Diseases, 61(11), 1703–1706. https://doi.org/10.1093/cid/civ638

Association of immune response to endothelial cell growth factor with early disseminated and late manifestations of lyme disease but not posttreatment lyme disease syndrome

Abstract

Author supplied keywords

Cite

Register to see more suggestions